FIELD: chemistry; pharmaceutics.
SUBSTANCE: invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, where Y is selected from a group consisting of p-fluorobenzoyl, trans-4-aminocyclohexyl, in which N is optionally substituted with R3, and trans-4-aminocyclohexylmethyl; Z is selected from a group consisting of NH, S and O; R1 is selected from a group consisting of hydrogen and halogen; R2 is selected from a group consisting of hydrogen, C3-C6 cycloalkyl, 4-tetrahydropyranyl, optionally substituted with R4, and phenyl, optionally substituted with R4; R3 is selected from a group consisting of C2-C6 alkanoyl and C1-C3 alkoxy (C1-C3) alkyl; R4 is selected from a group consisting of cyano and halogen. Invention also relates to a pharmaceutical composition for inhibiting cyclin-dependent kinase CDK9 based on said compound.
EFFECT: technical result is obtaining novel compounds and a pharmaceutical composition based thereon, which can be used in medicine for treating cancer diseases.
14 cl, 5 tbl, 14 dwg, 24 ex
Title | Year | Author | Number |
---|---|---|---|
PYRAZOLOPYRIMIDINE DERIVATIVE AND USE THEREOF | 2016 |
|
RU2735522C2 |
HETEROARYL COMPOUNDS, COMPOSITIONS CONTAINING THEM AND METHODS OF TREATING WITH USE OF SUCH COMPOUNDS | 2007 |
|
RU2478635C2 |
PYRAZOLAMINOPIRIMIDINE DERIVATIVES AS MODULATORS OF LEUCINE-REPEATING KINASE 2 | 2013 |
|
RU2637947C2 |
PYRAZOLO [3,4-C] PYRIDINES AND METHODS OF APPLICATION THEREOF | 2012 |
|
RU2638116C2 |
DERIVATIVES OF DIAMINES | 2002 |
|
RU2319699C2 |
BICYCLIC COMPOUND AND USE THEREOF FOR SUV39H2 INHIBITION | 2016 |
|
RU2729187C1 |
N-(2-CYANO HETEROCYCLYL)PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2669922C2 |
COMPOUNDS OF THIENOPYRIMIDINE | 2013 |
|
RU2637925C2 |
DIAMINE DERIVATIVES | 2002 |
|
RU2314303C2 |
NOVEL NICOTINAMIDE DERIVATIVE OR ITS SALT | 2011 |
|
RU2576623C2 |
Authors
Dates
2020-12-15—Published
2018-01-03—Filed